Therapeutic Cannabis Researchers
Here at P.A.C.E. we believe the world researchers and what they have to say about cannabis. We also believe you will once you've read or heard what they have to say. To help with that, below you will find some of the world leading cannabis researchers. Click on their picture and you will find some information about the researcher. Click on either the Youtube or Google links near their information in order to find out more on them and some of their researched articles.
Dr. Robert Melamede.... is the current CEO and president of Cannabis Science. Robert Melamede Ph.D. the former Chairman, and current professor, of the Biology Department atUniversity of Colorado, Colorado Springs. Dr. Melamede is a renown cannabinoid researcher, and teaches a class on cannabinoids. He recently spoke at the 7th Annual Patients Out of Time conference, giving a presentation on cannabis oil and skin cancer. Cannabis Science Inc. is a start-up biotech company based in Colorado Springs, CO. Cannabis Science was incorporated in 2009 and trades publicly under the ticker CBIS on the Over-The-Counter Bulletin Board (OTCBB:CBIS). Their goal is to get Cannabis based medicines approved by the FDA, with current focus on Skin Cancer (basal and squamous cell carcinomas), PTSD and HIV as stated in Press Releases
Go to Google & Youtube to learn more about Dr. Melamede
Go to Google & Youtube to learn more about Dr. Melamede
Dr. William Courtney.....has an extensive medical education that began with a Bachelor of Science in Microbiology from the University of Michigan. He also received his Doctor of Medicine from Wayne State University, and Interned for Residency in Psychiatry at California Pacific Medical Center and went on to earned his Post Doctorate in Forensic Examination and Forensic Medicine. Dr. Courtney is currently a member of American Academy of Cannabinoid Medicine, the International Cannabinoid Research Society, the International Association of Cannabis as Medicine, and the Society of Clinical Cannabis. Dr. Courtney has also been teaching Continuing Medical Education courses in clinical cannabis
Go to Google & Youtube to learn more about Dr. Courtney
Go to Google & Youtube to learn more about Dr. Courtney
Dr. David Bearman.......... received his M.D. from the University of Washington School of Medicine. He graduated with honors from the University of Wisconsin with an undergraduate degree in Psychology. He was the Director of Medical Services for the Santa Barbara Regional Health Authority (SBRHA) since its inception in 1983 through June 1997, and was then promoted to Senior Health Care Advisor/Grants Development Director. In 1999 as a result of Dr. Bearman's efforts, the California Healthcare Foundation allocated ten (10) million dollars to several healthentities located in Santa Barbara County for a county-wide medical data exchange system. SBRHA is the oldest County Organized Health System (COHS) in California and the U.S.
Go to Google & Youtube to learn more about Dr. Bearman
Go to Google & Youtube to learn more about Dr. Bearman
Dr. Lester Grinspoon .......is Associate Professor Emeritus ofPsychiatry at Harvard Medical School. Grinspoon was senior psychiatrist at the Massachusetts Mental Health Center in Boston for 40 years. Dr. Grinspoon is a fellow of the American Association for the Advancement of Science and the American Psychiatric Association. When Grinspoon began studying marijuana in 1967, his intention was to "define scientifically the nature and degree of those dangers" but as he reviewed the existing literature on the subject Grinspoon reached the conclusion he and the general public had been misinformed and misled. "There was little empirical evidence to support my beliefs about the dangers of marijuana," and he was convinced cannabis was much less harmful than he had believed. The title of Marihuana Reconsidered "reflected that change in view."
Go to Google & Youtube to learn more about Dr. Grinspoon
Go to Google & Youtube to learn more about Dr. Grinspoon
Dr. Ethan Russo ...... is a full-time consultant with GW Pharmaceuticals, which makes Sativex, a cannabis-based medicine approved in Canada for pain linked to multiple sclerosis and cancer. Russo, who had a neurology practice for 20 years, has previously published studies examining the history of cannabis.
Go to Google & Youtube to learn more about Dr. Russo
Dr. Ethan Russo ...... is a full-time consultant with GW Pharmaceuticals, which makes Sativex, a cannabis-based medicine approved in Canada for pain linked to multiple sclerosis and cancer. Russo, who had a neurology practice for 20 years, has previously published studies examining the history of cannabis.
Go to Google & Youtube to learn more about Dr. Russo
Dr. Raphael Mechoulam .....is an Israeli professor of Medicinal Chemistry andNatural Products at the Hebrew University of Jerusalem in Israel. Mechoulam is best known for his work (together with Y. Gaoni) in the isolation, structure elucidation and total synthesis of Δ9-tetrahydrocannabinol, the main active principle of cannabis and for the isolation and the identification of the endogenous cannabinoids anandamidefrom the brain and 2-arachidonoyl glycerol (2-AG) from peripheral organs together with his students, postdocs and collaborators.
Go to Google & Youtube to learn more about Dr. Mechoulam
Go to Google & Youtube to learn more about Dr. Mechoulam
Dr. Donald I. Abrams...... is a cancer and integrative medicine specialist at the UCSF Osher Center for Integrative Medicine at Mount Zion. Abrams provides integrative medicine consultations for cancer patients and has completed research in complementary and alternative therapies including mind-body treatments, botanical therapies, medical use of marijuana and traditional Chinese medicine herbal therapies.
Go to Google & Youtube to learn more about Dr. Abrams
Go to Google & Youtube to learn more about Dr. Abrams
Dr. Mark Ware....... is the Associate Medical Director of the McGill University Health Centre Pain Clinic and assistant professor in Family Medicine and Anesthesia at McGill University. Dr. Ware was born in London, England, and completed his medical training at the University of the West Indies in Kingston, Jamaica in 1992, followed by training in the UK in internal medicine and epidemiology. Since November 1999, he has been working as a pain physician at the Montreal General Hospital. Dr Ware receives research funding from the CIHR and salary support from the FRSQ. He lectures extensively on clinical pain management, including pharmacology, complementary approaches to chronic pain and the neurobiology of pain. His primary research interest is in the use of cannabinoids in pain and symptom management.
Go to Google & Youtube to learn more about Dr. Ware
Go to Google & Youtube to learn more about Dr. Ware
Dr. Donald Tashkin....... is Emeritus Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and an attending physician at the Ronald Reagan UCLA Medical Center.
Dr. Tashkin’s research interests include the pulmonary effects of smoked substance abuse and community air pollution, the pathophysiology, prevention and treatment of COPD, and the pathophysiology and clinical pharmacology of asthma. A prolific author and presenter, Dr. Tashkin has authored over 450 peer-reviewed journal articles as well as numerous book chapters, abstracts, editorials, and multimedia educational materials on various topics, including asthma, chronic obstructive pulmonary disease, airway disease management, lung cancer, and the health effects of cannabis and ‘crack’ cocaine. Dr. Tashkin has presented numerous times in various settings, including annual association and society meetings, national and international conferences and symposia, and pulmonary grand rounds. Among his many professional activities, he is a member of the Editorial Board of Chest, Respiratory Research and Respiratory Medicine and Guest Editor for numerous leading scholarly medical journals. He is Chair of the External Advisory Committee for the American Lung Association Asthma Clinical Research Centers. He is a member and serves as Chair of several other committees at UCLA.
Among his many honors and distinctions, Dr. Tashkin is the recipient of the 1999 American Lung Association Trudeau Award for many years of outstanding and dedicated service promoting pulmonary medicine, the American Lung Association of California’s 2003 California Medal for meritorious service in the campaign against lung disease and the 2010-2011 Dickson UCLA Emeritus Professorship Award and is listed in Who’s Who in America 2013.
Go to Google & Youtube to learn more about Dr. Tashkin
Dr. Tashkin’s research interests include the pulmonary effects of smoked substance abuse and community air pollution, the pathophysiology, prevention and treatment of COPD, and the pathophysiology and clinical pharmacology of asthma. A prolific author and presenter, Dr. Tashkin has authored over 450 peer-reviewed journal articles as well as numerous book chapters, abstracts, editorials, and multimedia educational materials on various topics, including asthma, chronic obstructive pulmonary disease, airway disease management, lung cancer, and the health effects of cannabis and ‘crack’ cocaine. Dr. Tashkin has presented numerous times in various settings, including annual association and society meetings, national and international conferences and symposia, and pulmonary grand rounds. Among his many professional activities, he is a member of the Editorial Board of Chest, Respiratory Research and Respiratory Medicine and Guest Editor for numerous leading scholarly medical journals. He is Chair of the External Advisory Committee for the American Lung Association Asthma Clinical Research Centers. He is a member and serves as Chair of several other committees at UCLA.
Among his many honors and distinctions, Dr. Tashkin is the recipient of the 1999 American Lung Association Trudeau Award for many years of outstanding and dedicated service promoting pulmonary medicine, the American Lung Association of California’s 2003 California Medal for meritorious service in the campaign against lung disease and the 2010-2011 Dickson UCLA Emeritus Professorship Award and is listed in Who’s Who in America 2013.
Go to Google & Youtube to learn more about Dr. Tashkin
Dr. Manual Guzman.... was born in Madrid (1963) and took his BSc (1986) and PhD (1990) in Biology from Madrid Complutense University. He is presently Full Professor of Biochemistry and Molecular Biology at that university. His PhD and postdoctoral research focused on the study of the regulation of liver and brain lipid metabolism. During the last dozen years he has been mostly involved in the study of how the active components of cannabis (the cannabinoids) act in the body, with especial emphasis on the molecular mechanisms of that action and on understanding how cannabinoids control cell generation and death. This work has allowed characterizing new effects and signalling pathways evoked by cannabinoids, as well as putting forward new physiopathological implications derived from them.
Go to Google and Youtube to learn
Go to Google and Youtube to learn
Dr. William Brooke O'Shaughness (October 1809 - January 1889) ...... was an Irish physician famous for his work in pharmacology and inventions related to telegraphy. His medical research led to the development of intravenous therapy and introduced the therapeutic use of Cannabis sativa to Western medicine. In India, he was a member of the Medical and Physical Society of Calcutta, where he published one of his first papers on medical applications of cannabis. He validated folk uses of cannabis in India, discovered new applications, and ultimately recommended cannabis for a great variety of therapeutic purposes. O’ Shaughnessy established his reputation by successfully relieving the pain of rheumatism and stilling the convulsions of an infant with cannabis. His most famous success came when he quelled the wrenching muscle spasm of tetanus and rabies with resin. While he could not cure tetanus, he did observe that the cannabis mixture reduced their symptoms of spasticity and their suffering. In 1841, he returned to England where he introduced cannabis indica to Western medicine and continued his scientific writings. He was elected a fellow of the Royal Society in 1843.
Click on this Google link to learn more
Click on this Google link to learn more
Dr Sean D McAllister - The McAllister lab focuses on the endocannabinoid system and how it controls cell growth and programmed cell death, particularly in aggressive cancers. He and colleagues have combined CB1 and CB2 (cloned cannabinoid receptor) agonists with non-psychotropic cannabinoids, to synergistically increase their anticancer effects in cell lines and animal models. Go to google or youtube to learn more to learn more about Dr. Sean MacAllister PhD.
Click on these Google and Youtube links to learn more
Click on these Google and Youtube links to learn more
Igor Grant Professor and Chair, Dept. of Psychiatry - University of California, San Diego
Director, Center for Medicinal Cannabis Research - University of California San Diego
Igor Grant, M.D.,...... is Distinguished Professor and Chair of the Department of Psychiatry at the University of California, San Diego School of Medicine. He directs the UCSD HIV Neurobehavioral Research Program, a multidisciplinary and interdepartmental program that focuses on the effects of HIV on the brain and behavior. As Director of the University of California Center for Medicinal Cannabis Research, Dr. Grant oversees clinical trials exploring the possible utility of cannabis compounds in the amelioration of certain severe manifestations of disease. Dr. Grant’s research has been supported by multiple NIH and VA awards, and has resulted in over 600 publications.
To learn more click here, watch this video or Google
Director, Center for Medicinal Cannabis Research - University of California San Diego
Igor Grant, M.D.,...... is Distinguished Professor and Chair of the Department of Psychiatry at the University of California, San Diego School of Medicine. He directs the UCSD HIV Neurobehavioral Research Program, a multidisciplinary and interdepartmental program that focuses on the effects of HIV on the brain and behavior. As Director of the University of California Center for Medicinal Cannabis Research, Dr. Grant oversees clinical trials exploring the possible utility of cannabis compounds in the amelioration of certain severe manifestations of disease. Dr. Grant’s research has been supported by multiple NIH and VA awards, and has resulted in over 600 publications.
To learn more click here, watch this video or Google
Lyle E. Craker... is a Professor in the Department of Plant, Soil and Insect Sciences at the University of Massachusetts Amherst. Since 2005, Craker has been trying to obtain a permit from the United States Drug Enforcement Administration (DEA) to grow marijuana for research purposes. Dr. Craker is known for proposing that medical grade marijuana be available for scientific studies into its possible health benefits. Since the marijuana available for studies is too weak for any kind of medical study, he proposed that medical grade marijuana be made available for research purposes. He has been named in many newspapers on this subject. The federal government refuses to give him a license to grow medical grade marijuana.
To learn more about Prof. Craker's click on these Google and Youtube links
To learn more about Prof. Craker's click on these Google and Youtube links
Dr. Jeffrey Hergenrather ....was recently named Medical Professional of the Year in the Americans for Safe Access’ 2015 Excellence Awards. He is also the President of the Society of Cannabis Clinicians, an organization representing physicians treating patients with cannabis.
Dr. Hergenrather has worked with hundreds of patients, carefully recording his observations along the way. At numerous CME-accredited medical conferences, he has delivered illuminating presentations on how cannabis treats diseases along with actual results from patients. For example, at the Patients Out of Time Eighth Clinical Conference on Cannabis Therapeutics, he helped lead the Doctors Workshop. His presentation included substantial information on cancer, including human success stories and the importance of THC:CBD ratios
To learn more about Dr. Hergenrather click on these Google and YouTube links.
Dr. Hergenrather has worked with hundreds of patients, carefully recording his observations along the way. At numerous CME-accredited medical conferences, he has delivered illuminating presentations on how cannabis treats diseases along with actual results from patients. For example, at the Patients Out of Time Eighth Clinical Conference on Cannabis Therapeutics, he helped lead the Doctors Workshop. His presentation included substantial information on cancer, including human success stories and the importance of THC:CBD ratios
To learn more about Dr. Hergenrather click on these Google and YouTube links.
Dr. Jody Corey-Bloom…… works at the forefront of clinical research on the causes and treatment of dementia and other neurodegenerative conditions associated, foremost, with Alzheimer's disease (AD), Huntington's disease (HD), and multiple sclerosis (MS). Her reputation for early and aggressive treatment was earned, locally and nationally, when the first disease-modifying therapies became available for clinical trials with Alzheimer's patients, and she has since never let up. Much to the supportive amusement of colleagues, under approval of the Drug Enforcement Agency after a two-decade hiatus of U.S. research on the medical uses of marijuana, she is principal investigator on a placebo-controlled clinical study of this drug's efficacy in relieving the muscle pain and rigidity of MS patients.
To Learn more about Dr. Cory-Bloom click on this Google link.
To Learn more about Dr. Cory-Bloom click on this Google link.
Suzanne A. "Sue" Sisley …… is a psychiatrist and former clinical assistant professor at the University of Arizona College of Medicine. She is known for her research into potential medical uses of marijuana.
In March 2014, Sisley's study of marijuana use to treat post-traumatic stress disorder (PTSD) was approved by the National Institute on Drug Abuse. After working at the University of Arizona for nearly eight years in various capacities, she was fired from the university in June 2014, ostensibly because of "funding and reorganization issues"; Sisley, however, maintained that it was because of her interest in studying the potential medical uses of marijuana to treat PTSD. Sisley has also claimed that her university failed to provide a location for the trial to take place, and that the University of Arizona was "fearful of the word 'marijuana' and [did] not want... their brand aligned with this research." After she was terminated, her university released a statement saying that they had "not received political pressure to terminate any employee as has been suggested in some media and other reports." Sisley has also acknowledged that she is "not sold" on the efficacy of marijuana for this purpose, but that she does think it has shown enough promise to be studied in a controlled environment. Since being fired, Sisley's research has been supported by the Multidisciplinary Association for Psychedelic Studies, a California-based nonprofit organization, which intends to look for a new university where it can be conducted. On July 28, the University of Arizona denied Sisley's appeal for reinstatement.
To learn more about Suzanne A. "Sue" Sisley , click on these Google or YouTube links.
In March 2014, Sisley's study of marijuana use to treat post-traumatic stress disorder (PTSD) was approved by the National Institute on Drug Abuse. After working at the University of Arizona for nearly eight years in various capacities, she was fired from the university in June 2014, ostensibly because of "funding and reorganization issues"; Sisley, however, maintained that it was because of her interest in studying the potential medical uses of marijuana to treat PTSD. Sisley has also claimed that her university failed to provide a location for the trial to take place, and that the University of Arizona was "fearful of the word 'marijuana' and [did] not want... their brand aligned with this research." After she was terminated, her university released a statement saying that they had "not received political pressure to terminate any employee as has been suggested in some media and other reports." Sisley has also acknowledged that she is "not sold" on the efficacy of marijuana for this purpose, but that she does think it has shown enough promise to be studied in a controlled environment. Since being fired, Sisley's research has been supported by the Multidisciplinary Association for Psychedelic Studies, a California-based nonprofit organization, which intends to look for a new university where it can be conducted. On July 28, the University of Arizona denied Sisley's appeal for reinstatement.
To learn more about Suzanne A. "Sue" Sisley , click on these Google or YouTube links.
Thank you for visiting our website and for being
People Advocating Cannabis Education
Updated and maintained by P.A.C.E. 11/18
People Advocating Cannabis Education
Updated and maintained by P.A.C.E. 11/18